Search
for
Sort by
Research 451–480 of 1000+
- Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: A cross sectional‐comparative study
- Niosomal and ethosomal gels: A comparative in vitro and ex vivo evaluation for repurposing of spironolactone
- 13777 The off-label use of spironolactone in female pattern hair loss
- Is spironolactone better than finasteride for symptoms of hirsutism in transgender women?
- Possible Spironolactone Induced Intracranial Hypertension in a Patient with Androgenetic Alopecia: A Case Report
- Spironolactone therapeutic effect in the hyperandrogenism syndrome
- (13) Tolerance of spironolactone
- Spironolactone use and oocyte maturation in patients undergoing controlled ovarian hyperstimulation
- Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Hair Loss, and Hirsutism
- Spironolactone versus Bicalutamide for Female Pattern Hair Loss: A 24-Month Unicenter Retrospective Comparative Study of Effectiveness and Safety
- Dual-drug nanostructured lipid carriers of spironolactone and 2-deoxy-D-ribose for targeted follicular delivery in androgenetic alopecia
- Spironolactone versus Bicalutamide in female pattern hair loss: A randomised clinical trial
- Beyond Boundaries: The Transformative Potential of Spironolactone in Female Pattern Hair Loss
- Beyond Boundaries: The Transformative Potential of Spironolactone in Female Pattern Hair Loss
- Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- Phenytoin or Spironolactone Intervention Counteracts 5-Fluorouracil–Induced Alopecia in Rats by Suppressing Oxidative Stress and Inflammation While Promoting Collagen Synthesis
- Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot study
- Low Risk of Hypotension in Women Treated with Spironolactone for Hair Loss
- 0415 Spironolactone treatment for dermatologic conditions and blood pressure changes in hypertensive patients on concomitant antihypertensive therapy
- Compatibility of 17-a-estradiol, Caffeine, Clobetasol Propionate, Finasteride Melatonin, Metronidazole, Spironolactone, Tretinoin, and Triamcinolone in Trichosol, a Natural Vehicle for Hair Solutions.
- Efficacy and Safety of Spironolactone in Acne Management
- Spironolactone reduces the risk of low-dose oral minoxidil-induced edema in women with female pattern hair loss.
- Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment
- Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment of Female Pattern Hair Loss: A Comparative, Clinical, and Trichoscopic Study
- Efficacy of oral spironolactone in the treatment of androgenetic alopecia in female patients: A case series of 11 patients
- Spironolactone
- Compatibility of 17-α-Estradiol, Betamethasone, Finasteride, Melatonin, Prednicarbate, and Spironolactone in TrichoFoam™ - a Foaming Vehicle for Personalized Alopecia Treatments.
- Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management
- Efficacy and safety of systemic spironolactone for acne in female patients in Sulaymaniyah teaching center of dermatology